The S&P/ASX 200 Index (ASX: XJO) has started the week in a positive fashion. In afternoon trade, the benchmark index is currently up 0.5% to 7,343.3 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why these ASX shares are rising:

Perenti Ltd (ASX: PRN)

The Perenti share price is up 9% to $1.26. Investors have been buying this mining contractor’s shares after its UMA joint venture won a major underground mining services contract. UMA has been awarded a new ~$630 million, 60-month contract at the Newmont Subika underground gold mine in Ghana.

Pointsbet Holdings Ltd (ASX: PBH)

The Pointsbet share price is up 17% to $1.82. This sports betting company’s shares are rebounding strongly after being sold off on Friday following the release of its quarterly update. Speculation that its North American business could be sold appears to be giving its shares a boost.

ResMed Inc. (ASX: RMD)

The ResMed share price is up 6% to $35.67. A number of brokers have responded very positively to this sleep treatment company’s quarterly update from the end of last week. For example, Citi has retained its buy rating and lifted its price target to $40.50 and Macquarie has retained its outperform rating with an improved price target of $38.00.

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix share price is up 3% to $10.47. This morning, this radiopharmaceuticals company released additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx in clear cell renal cell carcinoma. New data confirms its efficacy in masses 2cm or smaller.

The post Why Perenti, Pointsbet, ResMed, and Telix shares are rising today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• These were the best-performing ASX 200 shares in April
• Why Aeris, Brainchip, Pointsbet, and Syrah shares are falling today
• Pointsbet share price dives 8% amid potential to cash in with an offload
• ResMed share price higher on Q3 ‘solid beat’
• Better ASX 200 healthcare share: CSL vs. Resmed

Motley Fool contributor James Mickleboro has positions in Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended PointsBet and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended PointsBet. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/N3DUZaT

• Stock Market